Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.58 - $17.36 $1.04 Million - $1.33 Million
-76,794 Reduced 83.86%
14,779 $232,000
Q4 2023

Feb 14, 2024

SELL
$10.11 - $16.54 $63,126 - $103,275
-6,244 Reduced 6.38%
91,573 $1.48 Million
Q3 2023

Nov 14, 2023

BUY
$12.46 - $15.48 $383,693 - $476,691
30,794 Added 45.95%
97,817 $1.24 Million
Q2 2023

Aug 14, 2023

BUY
$13.28 - $15.96 $161,617 - $194,233
12,170 Added 22.19%
67,023 $943,000
Q1 2023

May 15, 2023

BUY
$14.26 - $22.1 $376,963 - $584,213
26,435 Added 93.02%
54,853 $847,000
Q4 2022

Feb 14, 2023

SELL
$14.85 - $19.04 $719,408 - $922,392
-48,445 Reduced 63.03%
28,418 $465,000
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $684,651 - $1.12 Million
55,303 Added 256.51%
76,863 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $684,651 - $1.12 Million
55,303 Added 256.51%
76,863 $1.42 Million
Q2 2022

Aug 16, 2022

SELL
$9.11 - $13.98 $389,589 - $597,854
-42,765 Reduced 66.48%
21,560 $284,000
Q1 2022

May 17, 2022

SELL
$6.87 - $11.11 $499,710 - $808,119
-72,738 Reduced 53.07%
64,325 $596,000
Q4 2021

Feb 15, 2022

BUY
$7.7 - $37.13 $872,487 - $4.21 Million
113,310 Added 477.03%
137,063 $1.34 Million
Q3 2021

Nov 16, 2021

BUY
$26.46 - $37.15 $70,224 - $98,596
2,654 Added 12.58%
23,753 $808,000
Q4 2020

Feb 17, 2021

BUY
$51.77 - $66.18 $292,086 - $373,387
5,642 Added 36.5%
21,099 $1.21 Million
Q3 2020

Nov 17, 2020

BUY
$43.8 - $58.16 $362,926 - $481,913
8,286 Added 115.55%
15,457 $793,000
Q2 2020

Aug 17, 2020

BUY
$37.05 - $65.03 $265,685 - $466,330
7,171 New
7,171 $428,000
Q1 2020

May 15, 2020

SELL
$33.63 - $69.4 $500,145 - $1.03 Million
-14,872 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $273,254 - $602,796
8,620 Added 137.88%
14,872 $926,000
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $124,727 - $242,890
6,252 New
6,252 $212,000
Q3 2018

Nov 14, 2018

SELL
$33.57 - $42.1 $948,822 - $1.19 Million
-28,264 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$20.06 - $44.95 $566,975 - $1.27 Million
28,264 New
28,264 $1.11 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.